Medical News
HIV
HIV
Individual-level Social Determinants of Health and Quality of Life Among Persons With Diagnosed HIV Infection Medical Monitoring Project, United States, 2021 Data Cycle (June 2021-May 2022)
Mon, 29 Apr 2024 12:00:00 EST
This report highlights aspects of individual-level SDOH-including socioeconomic status, health-related factors, neighborhood and built environment, and social and community context-and QoL among adults with diagnosed HIV.
Today is National Women and Girls HIV/AIDS Awareness Day (NWGHAAD)
Thu, 07 Mar 2024 14:00:00 EDT
March 10 is National Women and Girls HIV/AIDS Awareness Day (NWGHAAD), a time when organizations and communities across the United States come together to offer support, encourage discussion, and teach women and girls about the prevention of HIV, the importance of getting tested, and how to live with and manage HIV infection.
Notice of Funding Opportunity PS24-0020: Capacity Building Assistance (CBA) for HIV Prevention Programs to End the HIV Epidemic in the United States
Thu, 29 Feb 2024 13:34:00 EDT
CDC announces the competitive availability of fiscal year 2024 funds to implement a capacity building assistance (CBA) program to strengthen the capacity and improve the performance of the nation's HIV workforce.
HIV and Whole-Person Care
Wed, 14 Feb 2024 11:25:00 EDT
A whole-person approach to HIV prevention and treatment considers the multitude of factors affecting a person's health. The approach addresses healthcare and social service needs to engage and retain people in services regardless of whether the services are for HIV treatment or prevention.
HIV CDR Guidance for Health Departments
Wed, 14 Feb 2024 11:25:00 EDT
This guidance describes actions that all health departments can take to develop capacity, engage key partners, and successfully implement CDR activities.
Notice of Funding Opportunity PS24-0047: High-Impact HIV Prevention and Surveillance Programs for Health Departments
Mon, 12 Feb 2024 09:30:00 EDT
The purpose of this notice of funding opportunity (NOFO) is to implement a comprehensive HIV prevention and surveillance program to prevent new HIV infections and improve the health of peoples with HIV.
Quality of life and HIV stigma among National HIV/AIDS Strategy priority populations with HIV-Medical Monitoring Project, United States, 2017-2021
Fri, 26 Jan 2024 10:00:00 EDT
Using data from 2017-2021, this CDC report describes quality of life and HIV stigma, indicators for the National HIV/AIDS Strategy, among people with diagnosed HIV by priority populations.
Overview and Methodology of the National HIV Behavioral Surveillance Among Transgender Women - Seven Urban Areas, United States, 2019-2020
Tue, 23 Jan 2024 14:30:00 EDT
CDC assessed findings from a survey of transgender women, conducted in seven U.S. cities in 2019 and 2020, to better understand the factors associated with HIV prevention and care use among transgender women.
Prevalence of Discrimination and the Association Between Employment Discrimination and Health Care Access and Use - National HIV Behavioral Surveillance Among Transgender Women, Seven Urban Areas, United States, 2019-2020
Tue, 23 Jan 2024 14:30:00 EDT
Seven in 10 transgender women experienced at least one type of discrimination during the past 12 months; more than 30% experienced employment discrimination.
Social Support and the Association Between Certain Forms of Violence and Harassment and Suicidal Ideation Among Transgender Women - National HIV Behavioral Surveillance Among Transgender Women, Seven Urban Areas, United States, 2019-2020
Tue, 23 Jan 2024 14:30:00 EDT
Experiencing certain forms of violence and harassment and having low-moderate social support from any source was associated with a higher prevalence of suicidal ideation among transgender women.
Nonprescription Hormone Use Among Transgender Women - National HIV Behavioral Surveillance Among Transgender Women, Seven Urban Areas, United States, 2019-2020
Tue, 23 Jan 2024 14:30:00 EDT
Transgender women who reported recent health care use or insurance coverage for gender-affirming hormone treatment (GAHT) were less likely to report nonprescription GAHT, and those reporting recent exchange sex or recent homelessness were more likely to report nonprescription GAHT.
Transgender Women Experiencing Homelessness - National HIV Behavioral Surveillance Among Transgender Women, Seven Urban Areas, United States, 2019-2020
Tue, 23 Jan 2024 14:30:00 EDT
Among transgender women, 4 in 10 reported experiencing homelessness at any point during the past 12 months.
Structural and Psychosocial Syndemic Conditions and Condomless Anal Intercourse Among Transgender Women - National HIV Behavioral Surveillance Among Transgender Women, Seven Urban Areas, United States, 2019-2020
Tue, 23 Jan 2024 14:30:00 EDT
Reporting more syndemic (co-occurring) conditions was associated with an increased prevalence of sexual behavior among transgender women.
Characteristics Associated with Pre-Exposure Prophylaxis Discussion and Use Among Transgender Women Without HIV Infection - National HIV Behavioral Surveillance Among Transgender Women, Seven Urban Areas, United States, 2019-2020
Tue, 23 Jan 2024 14:30:00 EDT
Although 57% of surveyed transgender women without HIV had discussed PrEP with a clinician, only 32% had recently used it.
Core Indicators for Monitoring the Ending the HIV Epidemic Initiative (Preliminary Data): National HIV Surveillance System Data Reported through September 2023; and Preexposure Prophylaxis (PrEP) Data Reported through June 2023
Thu, 14 Dec 2023 12:00:00 EDT
The tables included in this report provide preliminary data on HIV diagnoses and linkage to HIV medical care for the years 2022 and 2023 based on cases reported to CDC as of September 2023. Data on preexposure prophylaxis (PrEP) coverage are provided for the years 2019, 2020, 2021, 2022, and 2023 (preliminary). Data for the 3 indicators are provided at the national, state, and county levels (EHE Phase I jurisdictions only).
HIV and HCV Infection and Related Behaviors Among Persons Who Use Drugs-6 U.S. Syringe Services Programs, 2021-2022
Tue, 12 Dec 2023 09:00:00 EDT
This report summarizes findings from IDU-SP data collection among persons who use drugs, conducted June 2021 through July 2022.
Notice of Funding Opportunity PS-24-042: A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released from Prison
Tue, 05 Dec 2023 10:00:00 EDT
The purpose of this NOFO is to support research on long-acting injectable (LAI) antiretroviral therapy (ART) by implementing and evaluating LAI-ART use among people soon to be released from prisons to the community and the effects of such use on the achievement and maintenance of HIV care continuum metrics. Recipients of this NOFO will conduct qualitative and quantitative research resulting in data describing real-world LAI-ART use in an era of multiple HIV treatment modalities.
Notice of Funding Opportunity Announcement PS24-063: Minority HIV Research Initiative (MARI): Epidemiologic, Behavioral, and Implementation Science Research in Racial/Ethnic Minority Communities Disproportionately Affected by HIV and Build Research Capacity Among Historically Underrepresented Researchers
Mon, 27 Nov 2023 09:30:00 EDT
The purpose of this Notice of Funding Opportunity (NOFO) is to support promising epidemiologic, behavioral, and implementation science research addressing the drivers of health inequities in racial and ethnic minority communities disproportionately affected by HIV while strengthening the capacity for conducting such research among underrepresented investigators working in these communities. The NOFO supports CDC's goals to promote health and reduce disease and disability by funding research that has the potential to result in high public health impact.
Engaging with Transgender & Nonbinary Communities Social Media Toolkit
Tue, 24 Oct 2023 12:00:00 EST
Looking to share inclusive and affirming HIV information for trans, nonbinary, and gender non-conforming (GNC) communities? We've got you covered! This edition of our Let's Stop HIV Together social media toolkit contains ready-to-go messages for posting on Instagram, Facebook, and Twitter.
HIV and Stage 3 (AIDS) Classifications Data through December 2021 Provided for the Ryan White HIV/AIDS Program, for Fiscal Year 2023
Wed, 18 Oct 2023 15:00:00 EST
The FY 2023 Ryan White Supplemental Surveillance Report displays data that were provided by CDC to the HIV/AIDS Bureau of the Health Resources and Services Administration to calculate funding allocation amounts for jurisdictions eligible for the Ryan White HIV/AIDS Program (RWHAP) Metropolitan (Part A) and State (Part B) programs.
Dear Colleague: Preliminary Data on Pre-Exposure Prophylaxis Coverage Released
Wed, 18 Oct 2023 12:45:00 EST
CDC published preliminary data on pre-exposure prophylaxis (PrEP) coverage. These preliminary data (Tables 3A-3C) indicate that in 2022, for the first time, more than one-third of people in the U.S. who could benefit from PrEP had been prescribed it. Increasing PrEP coverage is one of the key prevention strategies outlined in the Ending the HIV Epidemic in the U.S. (EHE) initiative.
Core Indicators for Monitoring the Ending the HIV Epidemic Initiative (Preliminary Data): National HIV Surveillance System Data Reported through June 2023; and Preexposure Prophylaxis (PrEP) Data Reported through March 2023
Tue, 17 Oct 2023 12:01:00 EST
The tables included in this report provide preliminary data on HIV diagnoses and linkage to HIV medical care for the years 2022 and 2023 based on cases reported to CDC as of June 2023. Data on preexposure prophylaxis (PrEP) coverage are provided for the years 2019, 2020, 2021, 2022, and 2023 (preliminary). Data for the 3 indicators are provided at the national, state, and county levels (EHE Phase I jurisdictions only).
Social Determinants of Health among Adults with Diagnosed HIV Infection in the United States and Puerto Rico, 2021
Tue, 17 Oct 2023 12:00:00 EST
This report examines census tract-level social determinants of health (SDOH) among adults with diagnosed HIV infection in 2021 in the 50 states, the District of Columbia, and Puerto Rico. Data are presented for diagnoses of HIV infection, linkage to care, and viral suppression through 2021 among persons aged 18 years and older by 5 SDOH indicators and selected characteristics that include sex, age, race/ethnicity, and transmission category. This report also addresses health disparities and factors for special consideration in addressing health disparities.
Dear Colleague: National Latinx AIDS Awareness Day (NLAAD)
Thu, 12 Oct 2023 13:00:00 EST
October 15, 2023 is National Latinx AIDS Awareness Day, a day to focus on preventing HIV among Hispanics/Latinos and helping those living with HIV stay healthy.
Dear Colleague: September 27 is National Gay Men's HIV/AIDS Awareness Day (NGMHAAD)
Wed, 27 Sep 2023 11:30:00 EST
September 27 is National Gay Men's HIV/AIDS Awareness Day. Help raise awareness about HIV testing, prevention, and treatment among gay and bisexual men.
HIV Surveillance Special Report 32: Behavioral and Clinical Characteristics of Persons with Diagnosed HIV Infection-Medical Monitoring Project, United States 2021 Cycle (June 2021-May 2022)
Tue, 22 Aug 2023 11:00:00 EST
The National HIV/AIDS Strategy and the Ending the HIV Epidemic in the U.S. initiative aim to reduce new HIV transmissions in the United States by 90% by 2030 and prioritize reducing HIV-related disparities and health inequities and improving the health and well-being of people with HIV. The CDC Medical Monitoring Project (MMP) reports representative data on barriers to care and viral suppression, including social determinants of health and indicators of quality of life among adults with diagnosed HIV.
Core Indicators for Monitoring the Ending the HIV Epidemic Initiative (Preliminary Data): National HIV Surveillance System Data Reported through March 2023; and Preexposure Prophylaxis (PrEP) Data Reported through December 2022
Tue, 27 Jun 2023 13:30:00 EST
The tables included in this report provide preliminary data on HIV diagnoses for the years 2022 and 2023 and linkage to HIV medical care for the year 2022 based on cases reported to CDC as of March 2023. Data on preexposure prophylaxis (PrEP) coverage are provided for the years 2019, 2020, 2021, and 2022 (preliminary). Data for the 3 indicators are provided at the national, state, and county levels (EHE Phase I jurisdictions only).
Dear Colleague: June 27 is National HIV Testing Day
Mon, 26 Jun 2023 10:30:00 EST
June 27 is National HIV Testing Day (NHTD), a day to emphasize the importance of HIV testing. This year's theme, "Take the Test & Take the Next Step," highlights the power of HIV testing to give people the information they need to make decisions to keep themselves and their partners healthy, regardless of their test results.
Dear Colleague: CDC Releases New HIV Surveillance Reports
Tue, 23 May 2023 15:00:00 EST
CDC's Division of HIV Prevention released three new HIV surveillance reports.
Diagnoses of HIV infection in the United States and Dependent Areas, 2021
Tue, 23 May 2023 13:00:00 EST
The Centers for Disease Control and Prevention (CDC) collects, analyzes, and disseminates surveillance data on HIV infection; these data are one of the nation's primary sources of information on HIV in the United States. The annual surveillance report, published by CDC, summarizes information about diagnosed HIV infection in the United States and dependent areas.
Estimated HIV Incidence and Prevalence in the United States, 2017-2021
Tue, 23 May 2023 13:00:00 EST
This HIV Surveillance Supplemental Report provides estimates of HIV incidence, prevalence, and knowledge of HIV status in the United States and Puerto Rico for years 2017 through 2017.
Monitoring Selected National HIV Prevention and Care Objectives, 2021
Tue, 23 May 2023 13:00:00 EST
This report complements the HIV Surveillance Report and presents the results of focused analyses of National HIV Surveillance System (NHSS) data to measure progress toward achieving national HIV prevention and care goals. Data are presented among persons with diagnosed, perinatally acquired HIV infection and persons aged ≥13 years with diagnosed HIV for linkage to care, receipt of care, viral suppression; stage 3 (AIDS) at the time of diagnosis of HIV infection; and death and survival of persons with diagnosed HIV infection by selected characteristics that include gender (or assigned sex at birth where indicated), age, race/ethnicity, and transmission category (based on assigned sex at birth). For preexposure prophylaxis (PrEP), the number of persons who have been prescribed PrEP, the estimated number with PrEP indications, and PrEP coverage are presented. This report also presents the status and HIV-related disparities for linkage to care, viral suppression, and PrEP coverage.
Core Indicators for Monitoring the Ending the HIV Epidemic Initiative, National HIV Surveillance System Data Reported through December 2022 and PrEP Data Reported through September 2022
Tue, 23 May 2023 13:00:00 EST
The HIV surveillance data tables provide National the latest available data on the six indicators used for monitoring progress in the Ending the HIV Epidemic in the U.S. initiative.
HIV Infection, Stage 3 (AIDS) - 2021
Tue, 23 May 2023 13:00:00 EST
This slide set describes rates, percentages, and trends in the number (including cumulative data) of stage 3 (AIDS) classifications and persons living with diagnosed HIV infection ever classified as stage 3 (AIDS) in the United States and 6 dependent areas.
2021 HIV Mortality Slides
Tue, 23 May 2023 13:00:00 EST
The 2021 HIV Mortality Slide Set outlines trends in mortality in the United States, focusing on deaths attributed to HIV disease. Among persons with HIV disease as the underlying cause of death in 2021, males, Black and African American persons, residents of the South, and persons aged 45 years and older were the most impacted.
2021 Partner Services Annual Report
Mon, 17 Apr 2023 12:54:00 EST
This report summarizes the 2021 client-level partner services data from 54 of the 60 CDC-funded state and local health departments in the United States, Puerto Rico, and the U.S. Virgin Islands.
HIV Testing at CDC-Funded Sites: United States, Puerto Rico, and the U.S. Virgin Islands, 2021
Mon, 03 Apr 2023 08:01:00 EST
This report describes the demographics of persons tested, newly diagnosed with HIV, and linked to HIV medical care in the United States, Puerto Rico, and U.S. Virgin Islands in 2021. These data are used to assess the impact of CDC-funded HIV testing efforts, inform programmatic activities, and document the progress of programs toward local, state, and national HIV prevention goals.
PS18-1802 Monitoring and Evaluation Report, 2021
Thu, 30 Mar 2023 09:16:00 EST
The report highlights findings related to testing, linkage to care, interview for partner services, prevention services, and PrEP, by demographics, state prevalence, and population groups.
Join Us in Sharing and Promoting Together TakeMeHome (TTMH)
Tue, 21 Mar 2023 14:00:00 EST
Learn more about Together TakeMeHome (TTMH), a project with the goal of distributing up to 1 million free HIV self-tests over the next five years.
Vital Signs: Progress Toward Eliminating HIV as a Global Public Health Threat Through Scale-Up of Antiretroviral Therapy and Health System Strengthening Supported by the U.S. President's Emergency Plan for AIDS Relief - Worldwide, 2004-2022
Tue, 14 Mar 2023 13:37:00 EST
By 2022, approximately 20 million persons with HIV infection in 54 countries received PEPFAR-supported ART (62% CDC-supported); this number represents an increase of 300-fold from 66,6550 in 2004. During 2015-2022, viral load suppression rates increased from 80% to 95% among those who received testing.
Public Health Response to Clusters of Rapid HIV Transmission Among Hispanic or Latino Gay, Bisexual, and Other Men Who Have Sex with Men - Metropolitan Atlanta, Georgia, 2021-2022
Mon, 13 Mar 2023 11:00:00 EST
In 2021, molecular HIV analysis in Georgia identified clusters of rapid HIV transmission among Hispanic or Latino (Hispanic) gay, bisexual, and other men who have sex with men (MSM) in metropolitan Atlanta. A multicomponent investigation identified factors that might limit access to HIV services, including language barriers, immigration- and deportation-related concerns, and sexuality-related cultural norms. Health departments, providers, and community-based organizations collaborated to address these barriers.
Social Determinants of Health among Adults with Diagnosed HIV Infection in the United States and Puerto Rico, 2020
Thu, 09 Mar 2023 11:58:00 EDT
This report examines census tract-level social determinants of health (SDOH) among adults with diagnosed HIV infection in 2020 in the 50 states, the District of Columbia, and Puerto Rico. Data are presented for diagnoses of HIV infection, linkage to care, and viral suppression through 2020 among persons aged 18 years and older by 5 SDOH indicators and selected characteristics that include sex, age, race/ethnicity, and transmission category. This report also addresses health disparities and factors for special consideration in addressing health disparities.
Notice of Funding Opportunity PS23-001: Increasing PrEP Use Among Black Cisgender Women in the United States (HerPrEP)
Tue, 07 Mar 2023 09:15:00 EDT
The purpose of this NOFO is to support an implementation research study to evaluate strategies to increase HIV pre-exposure prophylaxis (PrEP) use among Black/African American (Black) cisgender women in the United States. The recipient should implement and evaluate strategies in healthcare clinics to increase PrEP provision by healthcare providers and PrEP use by Black cisgender women.
Notice of Funding Opportunity PS23-002: Enhancing Telehealth Strategies to Support Retention and Adherence to Antiretroviral Therapy (ART)
Wed, 01 Feb 2023 10:25:00 EDT
This Notice of Funding Opportunity will support research on evidence of effectiveness of TeleART by implementing a hybrid effectiveness-implementation research study.
Notice of Funding Opportunity PS23-003: Exploring Preferences for Long-Acting Antiretroviral Therapies (LA-ART) in a Community-Based Sample of Priority Populations Living with HIV Who are Disproportionately Affected
Wed, 01 Feb 2023 10:23:00 EDT
This Notice of Funding Opportunity will support qualitative research to inform strategies to strengthen uptake and adherence to ART and reduce existing disparities in HIV viral suppression among cis-gender Black women with HIV (CgBWH).
Dear Colleague: February 7 is National Black HIV/AIDS Awareness Day (NBHAAD)
Wed, 01 Feb 2023 10:00:00 EDT
Read this year's NBHAAD Dear Colleague Letter to learn how you can help us raise awareness about HIV testing, prevention, and treatment for African American people.
Notice of Funding Opportunity PS-23-005: Expanding Rapid Initiation of Antiretroviral Therapy in Non-traditional Settings: Emergency Department
Thu, 26 Jan 2023 14:49:00 EDT
The purpose of this NOFO is to support research to investigate how to deploy and optimize rapid ART delivery in emergency departments that are currently routinely screening for HIV infection. Emergency departments offer a unique opportunity to immediately engage with newly diagnosed patients to initiate ART and provide linkage to an HIV provider in the community. This research may help determine whether HIV testing and rapid ART in EDs can improve engagement, linkage and retention in care, and viral suppression among newly diagnosed people with HIV (PWH), as well as those previously diagnosed with HIV but who are not engaged in care.
Notice of Funding Opportunity PS-23-004: Long-Acting Injectables for the Treatment of HIV in Non-Clinic Community-Based Settings
Thu, 26 Jan 2023 14:48:00 EDT
The purpose of this NOFO is to support research on long-acting injectable (LAI) antiretroviral therapy (ART) by implementing LAI-ART administration in non-clinic settings. Utilizing an innovative strategy of LAI-ART administration in non-clinic-based settings to decentralize the delivery of LAI-ART for HIV treatment will expand treatment opportunities. Recipients of this NOFO will conduct qualitative and quantitative research resulting in data describing real-world LAI-ART use in an era of multiple HIV treatment modalities.
Notice of Funding Opportunity PS-23-006: Identifying and Addressing Historical and Structural Drivers of Medical Mistrust among Hispanic/Latino Gay, Bisexual and Other Men Who Have Sex with Men (HLMSM) for HIV Prevention. Applications are due on February 23, 2023.
Tue, 24 Jan 2023 11:04:00 EDT
This new funding opportunity announcement is an opportunity to (1) identify drivers of medical mistrust (MM) in Hispanic/Latino (H/L) populations in the United States with special attention to gay, bisexual and other men who have sex with men (HLMSM), and (2) address this social determinant of health by implementing and evaluating multilevel interventions in selected sites. Describing trauma from diverse H/L descent will lead to culturally centered and trustworthy multilevel interventions that will in turn decrease health disparities.
February 7 is National Black HIV/AIDS Awareness Day (NBHAAD)
Mon, 23 Jan 2023 11:48:00 EDT
NBHAAD is a day to increase awareness about HIV among African Americans and encourage people to get involved in prevention efforts, get tested, get treatment if they have HIV, and use prevention tools such as pre-exposure prophylaxis (PrEP) or condoms if they do not have HIV. It is also a day to work toward reducing HIV-related stigma.
HIV Surveillance Data Tables: Core Indicators for Monitoring the Ending the HIV Epidemic in the U.S. initiative
Thu, 15 Dec 2022 11:57:00 EDT
The tables included in this report provide preliminary data on HIV diagnoses and linkage to HIV medical care reported to CDC as of September 2022 for the years 2021 and 2022, and data on preexposure prophylaxis (PrEP) coverage for the years 2019, 2020, 2021, and 2022 (preliminary).
HIV Mortality 2020 Slide Set
Mon, 12 Dec 2022 11:21:00 EDT
The 2020 HIV Mortality Slide Set outlines trends in mortality in the United States, focusing on deaths attributed to HIV disease. Among persons with HIV disease as the underlying cause of death in 2020, males, Black and African American persons, residents of the South, and persons aged 45 years and older were the most impacted.
Dear Colleague: CDC Observes World AIDS Day
Thu, 01 Dec 2022 14:01:00 EDT
World AIDS Day observed each year on December 1, is an opportunity for people worldwide to unite in the fight against HIV, show their support for people living with HIV, and remember those who have died.
Issue Brief: The Role of Housing in Ending the HIV Epidemic
Thu, 01 Dec 2022 11:40:00 EDT
This issue brief highlighting how CDC, other federal agencies & community partners are collaborating to equitably address housing & HIV care needs through funding, program implementation & research
World AIDS Day Toolkit
Wed, 02 Nov 2022 09:56:00 EST
Find and share social media posts to raise HIV awareness among people worldwide and encourage them to get tested and know their prevention options.
DHP Strategic Plan Supplement 2022-2025
Thu, 13 Oct 2022 21:41:00 EST
DHP developed refreshed priorities to support the existing 2017-2020 Strategic Plan and to better align division priorities with the 2022-2025 National HIV/AIDS Strategy (NHAS) and the Ending the HIV Epidemic in the United States (EHE) initiative. The strategies outlined in the supplement will further enable DHP to deliver on the strategic goals and objectives from the existing 2017-2020 Strategic Plan over the next three years
October 15 is National Latinx AIDS Awareness Day (NLAAD)
Thu, 13 Oct 2022 14:00:00 EST
This NLAAD, join us in celebrating the progress in HIV prevention among Hispanic/Latino people.
HIV Stigma and Health Care Discrimination Experienced by Hispanic or Latino Persons with HIV - United States, 2018-2020
Thu, 13 Oct 2022 13:43:00 EST
Among 1,969 persons with monkeypox in eight U.S. jurisdictions, 38% had HIV infection, and 41% had an STI in the preceding year. Among persons with monkeypox, hospitalization was more common among persons with HIV infection than persons without HIV infection.
HIV Infographics Library
Thu, 29 Sep 2022 13:45:00 EST
CDC's new HIV infographics library has more than 200 charts on HIV. Download and share them to help raise awareness about HIV prevention and treatment.
Core Indicators for Monitoring the Ending the HIV Epidemic Initiative (Preliminary Data): National HIV Surveillance System Data Reported through June 2022; and Preexposure Prophylaxis (PrEP) Data Reported through March 2022
Thu, 29 Sep 2022 11:54:00 EST
This report is a quarterly update of data on 3 indicators for monitoring the Ending the HIV Epidemic in the U.S. initiative. Data on HIV diagnoses and linkage to HIV medical care are provided through June 2022. Data on PrEP coverage is provided through March 2022.
Dear Colleague: September 27 is National Gay Men's HIV/AIDS Awareness Day (NGMHAAD)
Thu, 22 Sep 2022 14:00:00 EST
September 27 is National Gay Men's HIV/AIDS Awareness Day. Help raise awareness about HIV testing, prevention, and treatment among gay and bisexual men.
2020 Partner Services Annual Report
Fri, 16 Sep 2022 10:17:00 EST
This report summarizes the 2020 client-level partner services data from 53 of the 60 CDC-funded state and local health departments in the United States, Puerto Rico, and the U.S. Virgin Islands.
HIV and Sexually Transmitted Infections Among Persons with Monkeypox - Eight U.S. Jurisdictions, May 17-July 22, 2022
Fri, 09 Sep 2022 15:00:00 EST
Among 1,969 persons with monkeypox in eight U.S. jurisdictions, 38% had HIV infection, and 41% had an STI in the preceding year. Among persons with monkeypox, hospitalization was more common among persons with HIV infection than persons without HIV infection.
Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data United States and 6 Dependent Areas, 2020
Wed, 31 Aug 2022 09:39:00 EST
The report "Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data United States and 6 Dependent Areas, 2020" has been updated to include five new quality of life indicators (Table 10) announced with the release of the National HIV/AIDS Strategy (NHAS) Federal Implementation Plan. This updated report, originally released in May 2022, was re-published on the CDC website on August 26, 2022.
Modeling the Impact of Sexual Networks in the Transmission of Monkeypox virus Among Gay, Bisexual, and Other Men Who Have Sex With Men - United States, 2022
Tue, 30 Aug 2022 11:06:00 EST
The 2022 monkeypox outbreak is associated with sexual and intimate contact. Survey data suggest that gay, bisexual, and other men who have sex with men (MSM), who have been disproportionately affected, are reducing one-time partnerships.
Strategies Adopted by Gay, Bisexual, and Other Men Who Have Sex with Men to Prevent Monkeypox virus Transmission - United States, August 2022
Tue, 30 Aug 2022 11:04:00 EST
In a recent survey of gay, bisexual, and other men who have sex with men, approximately one half reported reducing their number of sex partners, one-time sexual encounters, and use of dating apps because of the monkeypox outbreak. Receipt of vaccine to protect against monkeypox varied by race, ethnicity, and geography.
Issue Brief: Status-Neutral HIV Care and Service Delivery
Tue, 23 Aug 2022 15:55:00 EST
This issue briefs describes CDC's approach to status neutral HIV care.
Core Indicators for Monitoring the Ending the HIV Epidemic in the United States Initiative
Tue, 09 Aug 2022 12:01:00 EST
This set of HIV Surveillance Data Tables provides the most current data on core indicators for monitoring the Ending the HIV Epidemic in the United States Initiative. Data on HIV diagnoses and linkage to HIV medical care reported through the National HIV Surveillance System through March 2022, and PrEP data reported through December 2021 are included in this release.
Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection - United States, August 2022
Fri, 05 Aug 2022 13:19:00 EST
A multinational monkeypox outbreak disproportionately affecting men who have sex with men, including persons with HIV infection, is ongoing worldwide.
Integrated HIV Surveillance & Prevention Programs for Health Departments (PS18-1802): Monitoring and Evaluation Report, 2020
Thu, 28 Jul 2022 07:01:00 EST
CDC's National HIV Prevention Program Monitoring and Evaluation (NHM&E) data are presented that monitor the impact of CDC-funded HIV testing efforts and programmatic activities, and progress toward achieving the national HIV prevention goals from January through December 2020
Behavioral and Clinical Characteristics of Persons with Diagnosed HIV Infection Medical Monitoring Project, United States 2020 Cycle (June 2020-May 2021)
Tue, 12 Jul 2022 13:05:00 EST
These are published data from the 2020 cycle (June 2020-May 2021) of the CDC Medical Monitoring Project, or MMP. The MMP is a surveillance system designed to learn more about the experiences and needs of people with HIV. The report provides information on behavioral and clinical outcomes affecting the risk of HIV transmission, morbidity, and mortality that are critical for achieving national HIV prevention goals.
EHE in Action: Telehealth in Kentucky
Thu, 07 Jul 2022 08:59:00 EST
With support from the EHR initiative, two organizations in rural Kentucky are using successful telehealth models to reach people with the care they need to stay healthy.
EHE in Action: HIV Self-Testing Success Story
Thu, 07 Jul 2022 08:58:00 EST
With support from the Ending the HIV Epidemic initiative and Minority HIV/AIDS Fund, CDC launched a new project to deliver 100,000 #HIV self-tests to key groups in communities heavily affected by HIV.
Monitoring EHE Progress
Thu, 07 Jul 2022 08:57:00 EST
This digital-first resource provides a user-friendly summary of CDC's HIV data organized by the EHE pillars: Diagnose, Treat, Prevent, and Respond. This data is used to track the nation's progress towards ending the HIV epidemic.
HIV Testing Before and During the COVID-19 Pandemic - United States, 2019-2020
Tue, 28 Jun 2022 09:13:00 EST
HIV testing is the first step in accessing HIV prevention and care services. The COVID-19 pandemic disrupted health care delivery and might have affected HIV testing, which is critical to ending the HIV epidemic in the United States.
Dear Colleague: National HIV Testing Day is June 27!
Fri, 24 Jun 2022 12:57:00 EST
Read about trends in HIV testing and CDC's ongoing commitment to expanding HIV testing efforts.
Dear Colleague: HIV Surveillance Reports
Tue, 24 May 2022 14:02:00 EST
This Dear Colleague letter announces the publication of two new HIV surveillance reports and an AtlasPlus update. The COVID-19 pandemic in the United States led to disruptions in HIV testing services and access to clinical services throughout 2020. This disruption resulted in a steep, single-year decline in HIV diagnoses that is mostly attributed to declines in testing caused by less frequent visits to health centers, reduced outreach services, and shifting of public health staff to COVID-19 response activities. Given these disruptions, data for 2020 should be interpreted with caution.
Diagnoses of HIV infection in the United States and dependent areas, 2020
Tue, 24 May 2022 12:04:00 EST
The annual surveillance report summarizes information about diagnosed HIV infection in the United States and dependent areas. HIV surveillance data are used by CDC and their public health partners in other federal agencies, health departments, nonprofit organizations, academic institutions, and the public to help focus prevention efforts; plan services; allocate resources; develop policy; detect, monitor, and intervene in HIV clusters; and monitor trends in HIV infection.
Monitoring Selected National HIV Prevention and Care Objectives by Using HIV Surveillance Data-United States and 6 Dependent Areas, 2020
Tue, 24 May 2022 12:03:00 EST
This report complements the HIV Surveillance Report and presents the results of focused analyses of National HIV Surveillance System (NHSS) data to measure progress toward achieving national HIV prevention and care goals. Data for persons aged ≥13 years with diagnosed HIV are presented for linkage to care, receipt of care, viral suppression, stage 3 (AIDS) classifications at HIV diagnosis, deaths, and survival. Also included are data on perinatally acquired HIV infection in the U.S. and preexposure prophylaxis (PrEP) data (prescriptions, indications, and coverage) for persons aged ≥16 years.
HIV Surveillance Data Tables: Core Indicators for Monitoring the Ending the HIV Epidemic in the U.S. Initiative, NHSS Data through December 2021 and PrEP data through September 2021
Tue, 24 May 2022 12:02:00 EST
Report includes the latest data on the core indicators for monitoring the Ending the HIV Epidemic in the U.S. initiative.
HIV Surveillance Slide Set: HIV Infection, Stage 3 (AIDS)
Tue, 24 May 2022 12:01:00 EST
HIV surveillance slide set that presents data on trends in HIV infection stage 3 (AIDS) classifications.
Factors Associated with Use of HIV Prevention and Health Care Among Transgender Women - Seven Urban Areas, 2019-2020
Fri, 20 May 2022 16:00:00 EST
During 2019-2020, 38% of transgender women surveyed in seven major U.S. cities reported receiving a previous positive HIV test result. Low income (44%), experiencing homelessness (39%), and severe food insecurity (40%) were common and associated with lower likelihood of receipt of HIV prevention and health care; having a health care provider with whom the participant is comfortable was positively associated with receiving those services.
HIV in the United States by Region
Tue, 03 May 2022 11:10:00 EST
This updated web content provides information and data about HIV in the US Regions.
Issue Brief: HIV and Transgender Communities
Fri, 22 Apr 2022 15:00:00 EST
This issue brief describes what can be done to address key gaps in HIV prevention and care for transgender people.
HIV in the US by Race/Ethnicity
Thu, 14 Apr 2022 12:06:00 EST
This new web content provides information and statistical data about HIV in the United States by race/ethnicity.
Dear Colleague: Transgender HIV Testing Day
Thu, 14 Apr 2022 09:58:00 EST
National Transgender HIV Testing Day is observed each year on April 18. This day is an opportunity to focus on HIV testing, prevention, and treatment among transgender people. It encourages local testing events and testing campaigns to increase HIV status awareness in transgender populations.
HIV and Transgender People
Thu, 14 Apr 2022 09:02:00 EST
This updated web page provides information and statistical data about HIV and transgender people, including a fact sheet that visually displays this information.
HIV in the US by Age
Fri, 08 Apr 2022 11:39:00 EST
This new web content provides information and statistical data about HIV in the United States by age group.
Dear Colleague: PS 22-2203 Comprehensive High-Impact HIV Prevention Programs for Young Men of Color Who have Sex with Men and Young Transgender Persons of Color
Fri, 01 Apr 2022 12:59:00 EST
the Centers for Disease Control and Prevention (CDC) awarded funds to 36 community-based organizations (CBOs) under the program PS22-2203: Comprehensive High-Impact HIV Prevention Programs for Young Men of Color Who have Sex with Men and Young Transgender Persons of Color. Through this funding opportunity, CBOs will develop and implement high-impact HIV prevention programs for young men of color who have sex with men, young transgender persons of color, and their partners regardless of age, gender, and race/ethnicity.
Integrated Guidance for Developing Epidemiologic Profiles: HIV Prevention and Ryan White CARE Act Community Planning (Updated March 2022)
Thu, 17 Mar 2022 08:57:00 EST
The Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA) developed the Integrated Guidance for Developing Epidemiologic Profiles: HIV Prevention and Ryan White HIV/AIDS Program Planning to assist with compiling and interpreting HIV prevention, surveillance, and care data for state, territorial, or local HIV epidemiologic profiles. The document provides one set of guidance to help profile writers develop integrated epidemiologic profiles and to advise them how to interpret epidemiologic data in ways that are consistent with, and useful in, meeting the planning and evaluation needs of both HIV prevention and care programs.
Today is National Women and Girls HIV/AIDS Awareness Day (NWGHAAD)
Thu, 10 Mar 2022 17:25:00 EDT
March 10 is National Women and Girls HIV/AIDS Awareness Day (NWGHAAD), a time when organizations and communities across the United States come together to offer support, encourage discussion, and teach women and girls about the prevention of HIV, the importance of getting tested, and how to live with and manage HIV infection.
HIV and Women Web Content and Fact Sheet
Wed, 09 Mar 2022 17:26:00 EDT
This updated web content provides information and data about HIV among women in the US and dependent areas.
HIV Surveillance Report: Social Determinants of Health among Adults with Diagnosed HIV Infection, 2019
Wed, 09 Mar 2022 10:59:00 EDT
This report examines census tract-level social determinants of health (SDH) among adults with diagnosed HIV infection in 2019 in the 50 states, the District of Columbia, and Puerto Rico. Data are presented for diagnoses of HIV infection, linkage to care, and viral suppression through 2019 among persons aged 18 years and older by 5 SDH indicators and selected characteristics that include sex, age, race/ethnicity, and transmission category. This report also addresses health disparities and factors for special consideration in addressing health disparities.
HIV Prevention and Care Priorities - Regional Community Engagement Town Halls
Wed, 09 Mar 2022 09:03:00 EDT
The Division of HIV Prevention (DHP) is hosting our first HIV Prevention and Care Priorities - Regional Virtual Community Engagement Town Hall on, March 24 , 2022 10:30 - 12:00 p.m. EST with HHS Region 3. The Town Hall will provide a venue for discussion and collaboration focused on barriers to and opportunities for improving HIV diagnosis, treatment, prevention, and outbreak response.
Issue Brief: The Role of HIV Self-Testing in Ending the HIV Epidemic
Fri, 04 Mar 2022 10:27:00 EDT
HIV self-testing programs offer an innovative way to bridge gaps in access to HIV testing. To ensure that HIV self-testing services are available to all who could benefit from them, CDC conducts a range of activities to support and expand the implementation of self-testing.
Cluster Detection and Response FAQs
Wed, 02 Mar 2022 11:39:00 EDT
New web page with FAQs about HIV Cluster Detection and Response.
Dear Colleague: CDC Guideline modernization
Wed, 23 Feb 2022 13:22:00 EDT
CDC is modernizing its approach to clinical guidelines to reduce the time it takes to apply guidance to patient care and ensure that clinicians and patients can make informed decisions guided by the best available evidence to achieve optimal health outcomes.
Notice of Funding Opportunity PS22-2211: Enhanced Surveillance of Persons with Early and Late HIV Diagnosis
Wed, 23 Feb 2022 07:17:00 EDT
This NOFO is a re-announcement of PS22-2202. The purpose of this NOFO is to improve understanding of barriers and gaps in HIV prevention services that may lead to continued HIV transmission or delayed diagnosis of HIV. This NOFO will support enhanced surveillance of people diagnosed with HIV during the earliest and latest stages of infection (i.e., stages 0 and 3, respectively) to understand recent experiences with HIV prevention and testing services, as well as the system- and individual-level barriers that led to these failures in early diagnosis and prevention. Recipients of this NOFO will identify, locate, and recruit all persons diagnosed in the past year with stage 0 or stage 3 infection in their jurisdiction for participation in behavioral interviews conducted by a CDC contractor.
HIV and African American People Web Content and Fact Sheet
Thu, 10 Feb 2022 09:47:00 EDT
This web page provides updated information and statistical data about HIV and Black/African American people, including a fact sheet that visually displays this information.
